111 related articles for article (PubMed ID: 23431989)
1. Fluorescent SNAP-tag galectin fusion proteins as novel tools in glycobiology.
Kupper CE; Böcker S; Liu H; Adamzyk C; van de Kamp J; Recker T; Lethaus B; Jahnen-Dechent W; Neuss S; Müller-Newen G; Elling L
Curr Pharm Des; 2013; 19(30):5457-67. PubMed ID: 23431989
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Galectin Fusion Proteins with Glycoprotein Affinity Columns and Binding Assays.
Dey C; Palm P; Elling L
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770718
[TBL] [Abstract][Full Text] [Related]
3. Binding characteristics of galectin-3 fusion proteins.
Böcker S; Elling L
Glycobiology; 2017 May; 27(5):457-468. PubMed ID: 28104787
[TBL] [Abstract][Full Text] [Related]
4. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants.
Dam TK; Gabius HJ; André S; Kaltner H; Lensch M; Brewer CF
Biochemistry; 2005 Sep; 44(37):12564-71. PubMed ID: 16156668
[TBL] [Abstract][Full Text] [Related]
5. Purification of galectin-1 mutants using an immobilized Galactoseβ1-4Fucose affinity adsorbent.
Takeuchi T; Tamura M; Ishii N; Ishikida H; Sugimoto S; Suzuki D; Nishiyama K; Takahashi H; Natsugari H; Arata Y
Protein Expr Purif; 2015 Jul; 111():82-6. PubMed ID: 25858314
[TBL] [Abstract][Full Text] [Related]
6. Purification of Recombinant Galectins from Different Species Using Distinct Affinity Chromatography Methods.
Paul A; Wu SC; Patel KR; Ho AD; Allen JWL; Verkerke H; Arthur CM; Stowell SR
Methods Mol Biol; 2022; 2442():55-74. PubMed ID: 35320519
[TBL] [Abstract][Full Text] [Related]
7. Cross-link formation between mutant galectins of Caenorhabditis elegans with a substituted cysteine residue and asialofetuin via a photoactivatable bifunctional reagent.
Tamura M; Takeuchi T; Nonaka T; Kasai K; Arata Y
Biol Pharm Bull; 2011; 34(6):929-32. PubMed ID: 21628898
[TBL] [Abstract][Full Text] [Related]
8. The second glutamic acid in the C-terminal CRD affects the carbohydrate-binding properties of recombinant galectins of Haemonchus contortus.
Wang J; Yan R; Xu L; Li X
Vet Parasitol; 2007 Sep; 148(3-4):247-55. PubMed ID: 17643820
[TBL] [Abstract][Full Text] [Related]
9. Crosslinking of Cys-mutated human galectin-1 to the model glycoprotein ligands asialofetuin and laminin by using a photoactivatable bifunctional reagent.
Tamura M; Watanabe T; Igarashi T; Takeuchi T; Kasai K; Arata Y
Biol Pharm Bull; 2014; 37(5):877-82. PubMed ID: 24790011
[TBL] [Abstract][Full Text] [Related]
10. The Galβ-(syn)-gauche configuration is required for galectin-recognition disaccharides.
Iwaki J; Tateno H; Nishi N; Minamisawa T; Nakamura-Tsuruta S; Itakura Y; Kominami J; Urashima T; Nakamura T; Hirabayashi J
Biochim Biophys Acta; 2011 Jul; 1810(7):643-51. PubMed ID: 21514365
[TBL] [Abstract][Full Text] [Related]
11. Cloning, expression, and purification of galectins for in vitro studies.
Poland PA; Kinlough CL; Hughey RP
Methods Mol Biol; 2015; 1207():37-49. PubMed ID: 25253131
[TBL] [Abstract][Full Text] [Related]
12. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
13. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.
Sioud M; Mobergslien A; Boudabous A; Fløisand Y
Int J Oncol; 2011 Feb; 38(2):385-90. PubMed ID: 21165555
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the glycan specificities of cell-bound human tandem-repeat-type galectin-4, -8 and -9.
Vokhmyanina OA; Rapoport EM; André S; Severov VV; Ryzhov I; Pazynina GV; Korchagina E; Gabius HJ; Bovin NV
Glycobiology; 2012 Sep; 22(9):1207-17. PubMed ID: 22547138
[TBL] [Abstract][Full Text] [Related]
16. Generation and Use of Recombinant Galectins.
Wu SC; Paul A; Ho A; Patel KR; Allen JWL; Verkerke H; Arthur CM; Stowell SR
Curr Protoc; 2021 Mar; 1(3):e63. PubMed ID: 33656274
[TBL] [Abstract][Full Text] [Related]
17. Directed covalent immobilization of fluorescently labeled cytokines.
Recker T; Haamann D; Schmitt A; Küster A; Klee D; Barth S; Müller-Newen G
Bioconjug Chem; 2011 Jun; 22(6):1210-20. PubMed ID: 21528930
[TBL] [Abstract][Full Text] [Related]
18. Degraded Arabinogalactans and Their Binding Properties to Cancer-Associated Human Galectins.
Pfeifer L; Baumann A; Petersen LM; Höger B; Beitz E; Classen B
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920014
[TBL] [Abstract][Full Text] [Related]
19. Caenorhabditis elegans galectins LEC-1-LEC-11: structural features and sugar-binding properties.
Nemoto-Sasaki Y; Hayama K; Ohya H; Arata Y; Kaneko MK; Saitou N; Hirabayashi J; Kasai K
Biochim Biophys Acta; 2008 Oct; 1780(10):1131-42. PubMed ID: 18675319
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.
Nagae M; Nishi N; Nakamura-Tsuruta S; Hirabayashi J; Wakatsuki S; Kato R
J Mol Biol; 2008 Jan; 375(1):119-35. PubMed ID: 18005988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
